Download PDF
Journal of Pediatric Neurology 2020; 18(02): 055-078
DOI: 10.1055/s-0040-1702934
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Etiologies, Cerebral Vasomotion, and Endothelial Dysfunction in the Pathophysiology of Posterior Reversible Encephalopathy Syndrome in Pediatric Patients

Michael G. Z. Ghali
1   Department of Neurological Surgery, Houston Methodist Hospital, Houston, Texas, United States
,
Michael J. Styler
2   Department of Hematology and Oncology, Hahnemann University Hospital, Philadelphia, Pennsylvania, United States
› Author Affiliations Funding None.
Further Information

Publication History

06 October 2019

04 December 2019

Publication Date:
31 March 2020 (online)

Also available at
    Permissions and Reprints

Abstract

The posterior reversible encephalopathy syndrome was characterized by Hinchey and colleagues in the 1990s. The condition frequently afflicts patients suffering from hematologic and solid organ malignancy and individuals undergoing transplantation. Cases are more frequently described in the adult population compared with children. In the pediatric population, malignancy, transplantation, renal disease, and hypertension represent the most common etiologies. Theories on pathogenesis have centered upon cerebrovascular dysautoregulation with increases in blood–brain barrier permeability. This generates vasogenic edema of the cerebral parenchyma and consequent neurologic deficits. The parietal and occipital lobes are affected with greatest prevalence, though frontal and temporal lobe involvement is frequent, and that of the contents of the infratentorial posterior cranial fossa are occasionally described. The clinical presentation involves a characteristic constellation of neurologic signs and symptoms, most typically inclusive of headache, visual-field disturbances, abnormalities of visual acuity, and seizures. Supportive care, withdrawal of the offending agent, antihypertensive therapy, and prophylactic anticonvulsants affect convalescence in majority of cases. The principal challenge lies in identifying the responsible agent precipitating the condition in patients with malignancy and those having undergone transplantation and thus deciding which medication among a multidrug treatment regimen to withhold, the duration of drug cessation required to effect clinical resolution, and the safety of resuming treatment with the compound. We accordingly reviewed and evaluated the literature discussing the posterior reversible encephalopathy syndrome in children.

Keywords

posterior reversible encephalopathy syndrome - malignancy - chemotherapy - leukemia - mechanisms

Ethical Approval

All procedures were in accordance with the ethical standards committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.


Authors' Contributions

Michael G. Z. Ghali and Michael J. Styler contributed to conception of study and study design, acquisition of data, analysis and interpretation of data, drafting the manuscript and critically revising it for intellectual content. Both authors approved the final version of the manuscript.


 

  • References

  • 1 Peter P, George A. Posterior reversible encephalopathy syndrome and the pediatric population. J Pediatr Neurosci 2012; 7 (02) 136-138
    CrossrefPubMedSearch in Google Scholar
  • 2 Largeau B, Le Tilly O, Sautenet B, Salmon Gandonnière C, Barin-Le Guellec C, Ehrmann S. Arginine vasopressin and posterior reversible encephalopathy syndrome pathophysiology: the missing link?. Mol Neurobiol 2019; 56 (10) 6792-6806
    CrossrefPubMedSearch in Google Scholar
  • 3 Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 2015; 14 (09) 914-925
    CrossrefPubMedSearch in Google Scholar
  • 4 Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. Am J Neuroradiol 2008; 29 (06) 1036-1042
    CrossrefPubMedSearch in Google Scholar
  • 5 Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. Am J Neuroradiol 2008; 29 (06) 1043-1049
    CrossrefPubMedSearch in Google Scholar
  • 6 Yadav D, Garg L, Narwal P, Ladkany R, Franey L. Concomitant takotsubo cardiomyopathy with PRES syndrome: a coincidence or a real heart-brain connection?. J Cardiol Cases 2015; 12 (02) 48-51
    CrossrefPubMedSearch in Google Scholar
  • 7 Anastasopoulou S, Eriksson MA, Heyman M. , et al. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: clinical characteristics, risk factors, course, and outcome of disease. Pediatr Blood Cancer 2019; 66 (05) e27594
    CrossrefPubMedSearch in Google Scholar
  • 8 Gungor S, Kilic B, Tabel Y, Selimoglu A, Ozgen U, Yilmaz S. Clinical and imaging findings in childhood posterior reversible encephalopathy syndrome. Iran J Child Neurol 2018; 12 (01) 16-25
    PubMedSearch in Google Scholar
  • 9 Zama D, Gasperini P, Berger M. , et al; Supportive Therapy Working Group of Italian Pediatric Haematology and Oncology Association (AIEOP). A survey on hematology-oncology pediatric AIEOP centres: the challenge of posterior reversible encephalopathy syndrome. Eur J Haematol 2018; 100 (01) 75-82
    CrossrefPubMedSearch in Google Scholar
  • 10 Dandoy CE, Linscott LL, Davies SM. , et al. Clinical utility of computed tomography and magnetic resonance imaging for diagnosis of posterior reversible encephalopathy syndrome after stem cell transplantation in children and adolescents. Biol Blood Marrow Transplant 2015; 21 (11) 2028-2032
    CrossrefPubMedSearch in Google Scholar
  • 11 Fisler G, Monty MA, Kohn N, Assaad P, Trope R, Kessel A. Characteristics and outcomes of critically ill pediatric patients with posterior reversible encephalopathy syndrome. Neurocrit Care 2020; 32 (01) 145-151
    CrossrefPubMedSearch in Google Scholar
  • 12 Hurwitz RL, Mahoney Jr DH, Armstrong DL, Browder TM. Reversible encephalopathy and seizures as a result of conventional vincristine administration. Med Pediatr Oncol 1988; 16 (03) 216-219
    CrossrefPubMedSearch in Google Scholar
  • 13 Pihko H, Tyni T, Virkola K. , et al. Transient ischemic cerebral lesions during induction chemotherapy for acute lymphoblastic leukemia. J Pediatr 1993; 123 (05) 718-724
    CrossrefPubMedSearch in Google Scholar
  • 14 Garg RK. Posterior leukoencephalopathy syndrome. Postgrad Med J 2001; 77 (903) 24-28
    CrossrefPubMedSearch in Google Scholar
  • 15 Fraint E, Miller R, Walter A. Posterior reversible encephalopathy syndrome and cerebral sinus thrombosis in a case of pediatric B-cell ALL. J Pediatr Hematol Oncol 2017; 39 (02) e71-e73
    CrossrefPubMedSearch in Google Scholar
  • 16 Eilers B, Albers E, Law Y, McMullan DM, Shaw D, Kemna M. Posterior reversible encephalopathy syndrome after pediatric heart transplantation: increased risk for children with preexisting Glenn/Fontan physiology. Pediatr Transplant 2016; 20 (04) 552-558
    CrossrefPubMedSearch in Google Scholar
  • 17 Sanchez-Cendra C, Malon-Gimenez D, Guerra-Martinez JA, Calzas-Rodriguez J, Anton-Pascual B, Olmo-Sanchez A. Sindrome de encefalopatia posterior reversible asociado a quimioterapia. Gemcitabina como agente causal. Rev Neurol 2017; 64 (12) 574-575
    PubMedSearch in Google Scholar
  • 18 Newey CR, Chandrasekaran PN, Mohebbi MR. Posterior reversible encephalopathy syndrome after high-dose cytarabine in acute myelogenous leukemia. Neurol India 2017; 65 (01) 220
    PubMedSearch in Google Scholar
  • 19 Aradillas E, Arora R, Gasperino J. Methotrexate-induced posterior reversible encephalopathy syndrome. J Clin Pharm Ther 2011; 36 (04) 529-536
    CrossrefPubMedSearch in Google Scholar
  • 20 Hourani R, Abboud M, Hourani M, Khalifeh H, Muwakkit S. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children. Neuropediatrics 2008; 39 (01) 46-50
    Thieme ConnectPubMedSearch in Google Scholar
  • 21 Floeter AE, Patel A, Tran M. , et al. Posterior reversible encephalopathy syndrome associated with dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin) chemotherapy. Clin Lymphoma Myeloma Leuk 2017; 17 (04) 225-230
    CrossrefPubMedSearch in Google Scholar
  • 22 Navarro CE, Rodríguez PJ, Espitia OM. Fludarabine-induced posterior reversible encephalopathy syndrome in a pediatric patient with β-thalassemia: case report and literature review. Clin Neuropharmacol 2018; 41 (06) 224-229
    CrossrefPubMedSearch in Google Scholar
  • 23 Abughanimeh OK, Qasrawi AH, Tahboub MY, Abu Ghanimeh MK. Posterior reversible encephalopathy syndrome while receiving irinotecan with fluorouracil and folinic acid for metastatic gastric cancer. BJR Case Rep 2017; 4 (01) 20170033
    PubMedSearch in Google Scholar
  • 24 Truman N, Nethercott D. Posterior reversible encephalopathy syndrome (PRES) after treatment with oxaliplatin and 5-fluorouracil. Clin Colorectal Cancer 2013; 12 (01) 70-72
    CrossrefPubMedSearch in Google Scholar
  • 25 Hayase E, Sugita J, Fujimoto K. , et al. Posterior reversible encephalopathy syndrome following paralytic ileus caused by vincristine in a patient with T cell lymphoblastic lymphoma [article in Japanese]. Rinsho Ketsueki 2014; 55 (02) 249-253
    PubMedSearch in Google Scholar
  • 26 Ayesh Haj Yousef MH, Eyadeh A, Rawashdeh RA, Khasawneh R, Saleh JA, Jibreel MJ. Vinblastine-induced posterior reversible encephalopathy syndrome. J Oncol Pharm Pract 2019; 25 (08) 2019-2022
    CrossrefPubMedSearch in Google Scholar
  • 27 Hammerstrom AE, Howell J, Gulbis A, Rondon G, Champlin RE, Popat U. Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation. Am J Hematol 2013; 88 (04) 301-305
    CrossrefPubMedSearch in Google Scholar
  • 28 Park SE, Lee JY, Shin SJ, Kim CW, Kim SS. Cyclosporine-induced posterior reversible encephalopathy syndrome in a patient with pemphigus vulgaris. Ann Dermatol 2015; 27 (04) 454-456
    CrossrefPubMedSearch in Google Scholar
  • 29 Gheith O, Cerna M, Halim MA. , et al. Sirolimus-induced combined posterior reversible encephalopathy syndrome and lymphocytic pneumonitis in a renal transplant recipient: case report and review of the literature. Exp Clin Transplant 2017; 15 (Suppl. 01) 170-174
    PubMedSearch in Google Scholar
  • 30 Vilas-Boas S, Corte-Real A. Posterior reversible encephalopathy syndrome and azathioprine. Eur J Case Rep Intern Med 2019; 6 (01) 001032
    PubMedSearch in Google Scholar
  • 31 Onder AM, Lopez R, Teomete U. , et al. Posterior reversible encephalopathy syndrome in the pediatric renal population. Pediatr Nephrol 2007; 22 (11) 1921-1929
    CrossrefPubMedSearch in Google Scholar
  • 32 Thavamani A, Umapathi KK, Puliyel M, Super D, Allareddy V, Ghori A. Epidemiology, comorbidities, and outcomes of posterior reversible encephalopathy syndrome in children in the United States. Pediatr Neurol 2019; 22 (06) 527-535
    PubMedSearch in Google Scholar
  • 33 Parameswaran BK, Krishnan PR, Al Dossary J. Recurrent posterior reversible encephalopathy syndrome in a patient with sickle cell disease. Ann Saudi Med 2007; 27 (03) 206-211
    CrossrefPubMedSearch in Google Scholar
  • 34 D'Angelo P, Farruggia P, Lo Bello A. , et al. Reversible posterior leukoencephalopathy syndrome: report of 2 simultaneous cases in children. J Pediatr Hematol Oncol 2006; 28 (03) 177-181
    CrossrefPubMedSearch in Google Scholar
  • 35 Giussani A, Ardissino G, Belingheri M. , et al. Posterior reversible encephalopathy syndrome after kidney transplantation in pediatric recipients: two cases. Pediatr Transplant 2016; 20 (01) 68-71
    CrossrefPubMedSearch in Google Scholar
  • 36 Hayes Jr D, Adler B, Turner TL, Mansour HM. Alternative tacrolimus and sirolimus regimen associated with rapid resolution of posterior reversible encephalopathy syndrome after lung transplantation. Pediatr Neurol 2014; 50 (03) 272-275
    CrossrefPubMedSearch in Google Scholar
  • 37 Fernandez D, El-Azzabi TI, Jain V. , et al. Neurologic problems after pediatric liver transplantation and combined liver and bowel transplantations: a single tertiary centre experience. Transplantation 2010; 90 (03) 319-324
    CrossrefPubMedSearch in Google Scholar
  • 38 Saley T, Barton A, Sood SB, Thukaram R. Posterior reversible encephalopathy syndrome complicating ruptured appendicitis and abscess drainage in a previously healthy pediatric patient. J Pediatr Intensive Care 2019; 8 (02) 92-95
    Thieme ConnectPubMedSearch in Google Scholar
  • 39 Saad Aldin E, McNeely P, Menda Y. Posterior reversible encephalopathy syndrome on 18F-FDG PET/CT in a pediatric patient with Burkitt's lymphoma. Clin Nucl Med 2018; 43 (03) 195-198
    CrossrefPubMedSearch in Google Scholar
  • 40 Bhat RA, Wani Z, Baasit S, Khan I. Clinical course, laboratory parameters and outcome of TTP pediatric patients presenting with posterior reversible encephalopathy syndrome. Ren Fail 2015; 37 (06) 974-979
    CrossrefPubMedSearch in Google Scholar
  • 41 Beitinjaneh A, McKinney AM, Cao Q, Weisdorf DJ. Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011; 17 (03) 300-308
    CrossrefPubMedSearch in Google Scholar
  • 42 Habetz K, Ramakrishnaiah R, Raina SK, Fitzgerald RT, Hinduja A. Posterior reversible encephalopathy syndrome: a comparative study of pediatric versus adult patients. Pediatr Neurol 2016; 65: 45-51
    CrossrefPubMedSearch in Google Scholar
  • 43 Furtado A, Hsu A, La Colla L, Zuccoli G. Arterial blood pressure but not serum albumin concentration correlates with ADC ratio values in pediatric posterior reversible encephalopathy syndrome. Neuroradiology 2015; 57 (07) 721-728
    CrossrefPubMedSearch in Google Scholar
  • 44 Lucchini G, Grioni D, Colombini A. , et al. Encephalopathy syndrome in children with hemato-oncological disorders is not always posterior and reversible. Pediatr Blood Cancer 2008; 51 (05) 629-633
    CrossrefPubMedSearch in Google Scholar
  • 45 Cooney MJ, Bradley WG, Symko SC, Patel ST, Groncy PK. Hypertensive encephalopathy: complication in children treated for myeloproliferative disorders--report of three cases. Radiology 2000; 214 (03) 711-716
    CrossrefPubMedSearch in Google Scholar
  • 46 Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 2001; 24 (05) 361-364
    CrossrefPubMedSearch in Google Scholar
  • 47 Norman JK, Parke JT, Wilson DA, McNall-Knapp RY. Reversible posterior leukoencephalopathy syndrome in children undergoing induction therapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 2007; 49 (02) 198-203
    CrossrefPubMedSearch in Google Scholar
  • 48 Rathi B, Azad RK, Vasudha N, Hissaria P, Sawlani V, Gupta RK. L-asparaginase-induced reversible posterior leukoencephalopathy syndrome in a child with acute lymphoblastic leukemia. Pediatr Neurosurg 2002; 37 (04) 203-205
    CrossrefPubMedSearch in Google Scholar
  • 49 Gupta A, Swaroop C, Rastogi R, Garg R, Bakhshi S. Simultaneous occurrence of posterior reversible leukoencephalopathy syndrome in two cases of childhood acute lymphoblastic leukemia induction chemotherapy. Pediatr Hematol Oncol 2008; 25 (04) 351-358
    CrossrefPubMedSearch in Google Scholar
  • 50 Morris EB, Laningham FH, Sandlund JT, Khan RB. Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer 2007; 48 (02) 152-159
    CrossrefPubMedSearch in Google Scholar
  • 51 Niyadurupola N, Burnett CA, Allen LE. Reversible posterior leucoencephalopathy syndrome: a cause of temporary cortical blindness. Br J Ophthalmol 2005; 89 (07) 924-925
    CrossrefPubMedSearch in Google Scholar
  • 52 Shin RK, Stern JW, Janss AJ, Hunter JV, Liu GT. Reversible posterior leukoencephalopathy during the treatment of acute lymphoblastic leukemia. Neurology 2001; 56 (03) 388-391
    CrossrefPubMedSearch in Google Scholar
  • 53 González Quarante LH, Mena-Bernal JH, Martín BP. , et al. Posterior reversible encephalopathy syndrome (PRES): a rare condition after resection of posterior fossa tumors: two new cases and review of the literature. Childs Nerv Syst 2016; 32 (05) 857-863
    CrossrefPubMedSearch in Google Scholar
  • 54 Kridis WB, Mdhaffer M, Hentati Y. , et al. Posterior reversible encephalopathy syndrome in leukemic children: a sensitive issue. Curr Drug Saf 2015; 10 (02) 180-183
    CrossrefPubMedSearch in Google Scholar
  • 55 Shimizu Y, Tha KK, Iguchi A. , et al. Isolated posterior fossa involvement in posterior reversible encephalopathy syndrome. Neuroradiol J 2013; 26 (05) 514-519
    CrossrefPubMedSearch in Google Scholar
  • 56 McKinney AM, Short J, Truwit CL. , et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007; 189 (04) 904-912
    CrossrefPubMedSearch in Google Scholar
  • 57 Rubinstein LJ, Herman MM, Long TF, Wilbur JR. Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma. Cancer 1975; 35 (02) 291-305
    CrossrefPubMedSearch in Google Scholar
  • 58 Hinchey J, Chaves C, Appignani B. , et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334 (08) 494-500
    CrossrefPubMedSearch in Google Scholar
  • 59 Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002; 23 (06) 1038-1048
    PubMedSearch in Google Scholar
  • 60 Ahn KJ, You WJ, Jeong SL. , et al. Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping. Neuroradiology 2004; 46 (12) 978-983
    CrossrefPubMedSearch in Google Scholar
  • 61 Keyserling HF, Provenzale JM. Atypical imaging findings in a near-fatal case of posterior reversible encephalopathy syndrome in a child. AJR Am J Roentgenol 2007; 188 (01) 219-221
    CrossrefPubMedSearch in Google Scholar
  • 62 Kumar A, Keyrouz SG, Willie JT, Dhar R. Reversible obstructive hydrocephalus from hypertensive encephalopathy. Neurocrit Care 2012; 16 (03) 433-439
    CrossrefPubMedSearch in Google Scholar
  • 63 Grioni D, Pavan F, Prunotto G, Canonico F, Grandi C, Rovelli A. Should posterior reversible encephalopathy syndrome be mainly considered an epileptic disorder? Results of a sequential neurophysiological study in a pediatric cohort. Neuropediatrics 2017; 48 (02) 72-78
    Thieme ConnectPubMedSearch in Google Scholar
  • 64 Siebert E, Bohner G, Endres M, Liman TG. Clinical and radiological spectrum of posterior reversible encephalopathy syndrome: does age make a difference?--a retrospective comparison between adult and pediatric patients. PLoS One 2014; 9 (12) e115073
    CrossrefPubMedSearch in Google Scholar
  • 65 Khan SJ, Arshad AA, Fayyaz MB, Ud Din Mirza I. Posterior reversible encephalopathy syndrome in pediatric cancer: clinical and radiologic findings. J Glob Oncol 2018; 4: 1-8
    Search in Google Scholar
  • 66 Shkalim-Zemer V, Konen O, Levinsky Y. , et al. Calcineurin inhibitor-free strategies for prophylaxis and treatment of GVHD in children with posterior reversible encephalopathy syndrome after stem cell transplantation. Pediatr Blood Cancer 2017; 64 (11) e26531
    CrossrefPubMedSearch in Google Scholar
  • 67 Parasole R, Petruzziello F, Menna G. , et al. Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution. Leuk Lymphoma 2010; 51 (06) 1063-1071
    CrossrefPubMedSearch in Google Scholar
  • 68 Kim SJ, Im SA, Lee JW. , et al. Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia. Pediatr Neurol 2012; 47 (06) 436-442
    CrossrefPubMedSearch in Google Scholar
  • 69 Raj S, Killinger J, Overby P. Blood transfusion in sickle cell disease leading to posterior reversible encephalopathy syndrome (PRES). J Child Neurol 2013; 28 (10) 1284-1286
    CrossrefPubMedSearch in Google Scholar
  • 70 Raj S, Overby P, Erdfarb A, Ushay HM. Posterior reversible encephalopathy syndrome: incidence and associated factors in a pediatric critical care population. Pediatr Neurol 2013; 49 (05) 335-339
    CrossrefPubMedSearch in Google Scholar
  • 71 Khan RB, Sadighi ZS, Zabrowski J, Gajjar A, Jeha S. Imaging patterns and outcome of posterior reversible encephalopathy syndrome during childhood cancer treatment. Pediatr Blood Cancer 2016; 63 (03) 523-526
    CrossrefPubMedSearch in Google Scholar
  • 72 Zama D, Masetti R, Cordelli DM. , et al. Risk factor analysis of posterior reversible encephalopathy syndrome after allogeneic hematopoietic SCT in children. Bone Marrow Transplant 2014; 49 (12) 1538-1540
    CrossrefPubMedSearch in Google Scholar
  • 73 Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010; 85 (05) 427-432
    CrossrefPubMedSearch in Google Scholar
  • 74 Legriel S, Schraub O, Azoulay E. , et al; Critically III Posterior Reversible Encephalopathy Syndrome Study Group (CYPRESS). Determinants of recovery from severe posterior reversible encephalopathy syndrome. PLoS One 2012; 7 (09) e44534
    CrossrefPubMedSearch in Google Scholar
  • 75 Burnett MM, Hess CP, Roberts JP, Bass NM, Douglas VC, Josephson SA. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg 2010; 112 (10) 886-891
    CrossrefPubMedSearch in Google Scholar
  • 76 de-Lima-Oliveira M, Salinet ASM, Nogueira RC. , et al. Intracranial hypertension and cerebral autoregulation: a systematic review and meta-analysis. World Neurosurg 2018; 113: 110-124
    CrossrefPubMedSearch in Google Scholar
  • 77 Spetzler RF, Kalani MYS, Nakaji P. , eds. Neurovascular Surgery. 2nd ed. New York, NY: Thieme Publishers, Inc.; 2015
    Search in Google Scholar
  • 78 Michel E, Zernikow B, von Twickel J, Hillebrand S, Jorch G. Critical closing pressure in preterm neonates: towards a comprehensive model of cerebral autoregulation. Neurol Res 1995; 17 (02) 149-155
    CrossrefPubMedSearch in Google Scholar
  • 79 Brady KM, Mytar JO, Lee JK. , et al. Monitoring cerebral blood flow pressure autoregulation in pediatric patients during cardiac surgery. Stroke 2010; 41 (09) 1957-1962
    CrossrefPubMedSearch in Google Scholar
  • 80 Mchenry Jr LC, West JW, Cooper ES, Goldberg HI, Jaffe ME. Cerebral autoregulation in man. Stroke 1974; 5 (06) 695-706
    CrossrefPubMedSearch in Google Scholar
  • 81 Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev 1990; 2 (02) 161-192
    PubMedSearch in Google Scholar
  • 82 Panerai RB. Nonstationarity of dynamic cerebral autoregulation. Med Eng Phys 2014; 36 (05) 576-584
    CrossrefPubMedSearch in Google Scholar
  • 83 Grüne F, Kazmaier S, Stolker RJ, Visser GH, Weyland A. Carbon dioxide induced changes in cerebral blood flow and flow velocity: role of cerebrovascular resistance and effective cerebral perfusion pressure. J Cereb Blood Flow Metab 2015; 35 (09) 1470-1477
    CrossrefPubMedSearch in Google Scholar
  • 84 Smirl JD, Tzeng YC, Monteleone BJ, Ainslie PN. Influence of cerebrovascular resistance on the dynamic relationship between blood pressure and cerebral blood flow in humans. J Appl Physiol 1985; 2014 (116) 1614-1622
    PubMedSearch in Google Scholar
  • 85 Liu B, Zhang X, Zhang FC. , et al. Posterior reversible encephalopathy syndrome could be an underestimated variant of “reversible neurological deficits” in systemic lupus erythematosus. BMC Neurol 2012; 12: 152
    CrossrefPubMedSearch in Google Scholar
  • 86 McCulloch TJ, Turner MJ. The effects of hypocapnia and the cerebral autoregulatory response on cerebrovascular resistance and apparent zero flow pressure during isoflurane anesthesia. Anesth Analg 2009; 108 (04) 1284-1290
    CrossrefPubMedSearch in Google Scholar
  • 87 Hsu HY, Chern CM, Kuo JS, Kuo TB, Chen YT, Hu HH. Correlations among critical closing pressure, pulsatility index and cerebrovascular resistance. Ultrasound Med Biol 2004; 30 (10) 1329-1335
    CrossrefPubMedSearch in Google Scholar
  • 88 Czosnyka M, Richards HK, Whitehouse HE, Pickard JD. Relationship between transcranial Doppler-determined pulsatility index and cerebrovascular resistance: an experimental study. J Neurosurg 1996; 84 (01) 79-84
    CrossrefPubMedSearch in Google Scholar
  • 89 Piper IR, Chan KH, Whittle IR, Miller JD. An experimental study of cerebrovascular resistance, pressure transmission, and craniospinal compliance. Neurosurgery 1993; 32 (05) 805-815 , discussion 815–816
    CrossrefPubMedSearch in Google Scholar
  • 90 Emerson Jr TE, Heath C. Effects of local alterations of pCO2 and pH on cerebrovascular resistance in isolated dog heads. Proc Soc Exp Biol Med 1969; 130 (01) 318-322
    CrossrefPubMedSearch in Google Scholar
  • 91 Bjerregaard J, Jaffe RA. Cerebrovascular physiology. In: Spetzler RF, Kalani MYS, Nakaji P. , eds. Neurovascular Surgery. 2nd ed. New York, NY: Thieme Publishers, Inc.; 2015
    Search in Google Scholar
  • 92 Irudayanathan FJ, Wang N, Wang X, Nangia S. Architecture of the paracellular channels formed by claudins of the blood-brain barrier tight junctions. Ann N Y Acad Sci 2017; 1405 (01) 131-146
    CrossrefPubMedSearch in Google Scholar
  • 93 Bauer H, Traweger A. Tight junctions of the blood-brain barrier - a molecular gatekeeper. CNS Neurol Disord Drug Targets 2016; 15 (09) 1016-1029
    CrossrefPubMedSearch in Google Scholar
  • 94 Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 2001; 24 (12) 719-725
    CrossrefPubMedSearch in Google Scholar
  • 95 Xu L, Nirwane A, Yao Y. Basement membrane and blood-brain barrier. Stroke Vasc Neurol 2018; 4 (02) 78-82
    CrossrefPubMedSearch in Google Scholar
  • 96 Thomsen MS, Birkelund S, Burkhart A, Stensballe A, Moos T. Synthesis and deposition of basement membrane proteins by primary brain capillary endothelial cells in a murine model of the blood-brain barrier. J Neurochem 2017; 140 (05) 741-754
    CrossrefPubMedSearch in Google Scholar
  • 97 Banerjee J, Shi Y, Azevedo HS. In vitro blood-brain barrier models for drug research: state-of-the-art and new perspectives on reconstituting these models on artificial basement membrane platforms. Drug Discov Today 2016; 21 (09) 1367-1386
    CrossrefPubMedSearch in Google Scholar
  • 98 da Silva SM, Campos GD, Gomes FCA, Stipursky J. Radial glia-endothelial cells' bidirectional interactions control vascular maturation and astrocyte differentiation: impact for blood-brain barrier formation. Curr Neurovasc Res 2019; 16 (04) 291-300
    CrossrefPubMedSearch in Google Scholar
  • 99 Watkins S, Robel S, Kimbrough IF, Robert SM, Ellis-Davies G, Sontheimer H. Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells. Nat Commun 2014; 5: 4196
    CrossrefPubMedSearch in Google Scholar
  • 100 Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006; 7 (01) 41-53
    Search in Google Scholar
  • 101 Oehm E, Hetzel A, Els T. , et al. Cerebral hemodynamics and autoregulation in reversible posterior leukoencephalopathy syndrome caused by pre-/eclampsia. Cerebrovasc Dis 2006; 22 (2–3): 204-208
    CrossrefPubMedSearch in Google Scholar
  • 102 Naidu K, Moodley J, Corr P, Hoffmann M. Single photon emission and cerebral computerised tomographic scan and transcranial Doppler sonographic findings in eclampsia. Br J Obstet Gynaecol 1997; 104 (10) 1165-1172
    CrossrefPubMedSearch in Google Scholar
  • 103 Brewer J, Owens MY, Wallace K. , et al. Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am J Obstet Gynecol 2013; 208 (06) 468.e1-468.e6
    CrossrefPubMedSearch in Google Scholar
  • 104 Mukherjee P, McKinstry RC. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001; 219 (03) 756-765
    CrossrefPubMedSearch in Google Scholar
  • 105 Bartynski WS, Tan HP, Boardman JF, Shapiro R, Marsh JW. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol 2008; 29 (05) 924-930
    CrossrefPubMedSearch in Google Scholar
  • 106 Hefzy HM, Bartynski WS, Boardman JF, Lacomis D. Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. AJNR Am J Neuroradiol 2009; 30 (07) 1371-1379
    CrossrefPubMedSearch in Google Scholar
  • 107 Liman TG, Bohner G, Heuschmann PU, Endres M, Siebert E. The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: the retrospective Berlin PRES study. J Neurol 2012; 259 (01) 155-164
    CrossrefPubMedSearch in Google Scholar
  • 108 Cruz Jr RJ, DiMartini A, Akhavanheidari M. , et al. Posterior reversible encephalopathy syndrome in liver transplant patients: clinical presentation, risk factors and initial management. Am J Transplant 2012; 12 (08) 2228-2236
    CrossrefPubMedSearch in Google Scholar
  • 109 Tlemsani C, Mir O, Boudou-Rouquette P. , et al. Posterior reversible encephalopathy syndrome induced by anti-VEGF agents. Target Oncol 2011; 6 (04) 253-258
    CrossrefPubMedSearch in Google Scholar
  • 110 Li Y, Gor D, Walicki D. , et al. Spectrum and potential pathogenesis of reversible posterior leukoencephalopathy syndrome. J Stroke Cerebrovasc Dis 2012; 21 (08) 873-882
    CrossrefPubMedSearch in Google Scholar
  • 111 Everett CM, Turner B, Lobo M. Posterior reversible encephalopathy syndrome in (low renin) essential hypertension. J R Soc Med 2007; 100 (11) 522-523
    CrossrefPubMedSearch in Google Scholar
  • 112 Borovac JA, Božić J, Žaja N, Kolić K, Hrboka V. A global amnesia associated with the specific variant of posterior reversible encephalopathy syndrome (PRES) that developed due to severe preeclampsia and malignant hypertension. Oxf Med Case Rep 2016; 2016 (04) 76-80
    CrossrefPubMedSearch in Google Scholar
  • 113 Pavlakis SG, Frank Y, Chusid R. Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome. J Child Neurol 1999; 14 (05) 277-281
    CrossrefPubMedSearch in Google Scholar
  • 114 Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. Am J Neuroradiol 2000; 21 (07) 1199-1206
    PubMedSearch in Google Scholar
  • 115 Eguchi K, Kasahara K, Nagashima A. , et al. Two cases of malignant hypertension with reversible diffuse leukoencephalopathy exhibiting a reversible nocturnal blood pressure “riser” pattern. Hypertens Res 2002; 25 (03) 467-473
    CrossrefPubMedSearch in Google Scholar
  • 116 Belaramani KM, Lai V, Li CH, Lee AC, Kwong NS. Reversible posterior leukoencephalopathy syndrome in Chinese children induced by chemotherapy: a review of five cases. Hong Kong Med J 2011; 17 (01) 61-66
    PubMedSearch in Google Scholar
  • 117 Ozcakar ZB, Ekim M, Fitoz S. , et al. Hypertension induced reversible posterior leukoencephalopathy syndrome: a report of two cases. Eur J Pediatr 2004; 163 (12) 728-730
    CrossrefPubMedSearch in Google Scholar
  • 118 Prasad N, Gulati S, Gupta RK, Kumar R, Sharma K, Sharma RK. Is reversible posterior leukoencephalopathy with severe hypertension completely reversible in all patients?. Pediatr Nephrol 2003; 18 (11) 1161-1166
    CrossrefPubMedSearch in Google Scholar
  • 119 Singhi P, Subramanian C, Jain V, Singhi S, Ray M. Reversible brain lesions in childhood hypertension. Acta Paediatr 2002; 91 (09) 1005-1007
    CrossrefPubMedSearch in Google Scholar
  • 120 Mueller-Mang C, Mang T, Pirker A, Klein K, Prchla C, Prayer D. Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?. Neuroradiology 2009; 51 (06) 373-383
    CrossrefPubMedSearch in Google Scholar
  • 121 Karakis I, Macdonald JA, Stefanidou M, Kase CS. Clinical and radiological features of brainstem variant of hypertensive encephalopathy. J Vasc Interv Neurol 2009; 2 (02) 172-176
    PubMedSearch in Google Scholar
  • 122 Ay H, Buonanno FS, Schaefer PW. , et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998; 51 (05) 1369-1376
    CrossrefPubMedSearch in Google Scholar
  • 123 Moon SN, Jeon SJ, Choi SS. , et al. Can clinical and MRI findings predict the prognosis of variant and classical type of posterior reversible encephalopathy syndrome (PRES)?. Acta Radiol 2013; 54 (10) 1182-1190
    CrossrefPubMedSearch in Google Scholar
  • 124 Rabinstein AA, Mandrekar J, Merrell R, Kozak OS, Durosaro O, Fugate JE. Blood pressure fluctuations in posterior reversible encephalopathy syndrome. J Stroke Cerebrovasc Dis 2012; 21 (04) 254-258
    CrossrefPubMedSearch in Google Scholar
  • 125 Brejt JA, Golightly LM. Severe malaria: update on pathophysiology and treatment. Curr Opin Infect Dis 2019; 32 (05) 413-418
    CrossrefPubMedSearch in Google Scholar
  • 126 Fabbian F, Pala M, Fallica E. , et al. Posterior reversible encephalopathy syndrome in an 87-year-old woman with Escherichia coli bloodstream infection. Clin Exp Nephrol 2010; 14 (02) 176-179
    CrossrefPubMedSearch in Google Scholar
  • 127 Pala HG, Baris MM, Artunc Ulkumen B, Gurkan MA, Pala EE. Posterior reversible encephalopathy syndrome: an atypical complication of postpartum wound infection. J Obstet Gynaecol 2015; 35 (03) 306-308
    CrossrefPubMedSearch in Google Scholar
  • 128 Ramgopal A, Thavamani A, Ghori A. Association between posterior reversible encephalopathy syndrome and mycoplasma pneumoniae infection. J Pediatr Neurosci 2018; 13 (01) 109-111
    PubMedSearch in Google Scholar
  • 129 Stevenson J, Taylor C. Posterior reversible encephalopathy syndrome in disseminated histoplasmosis and advanced HIV infection. Int J STD AIDS 2014; 25 (08) 611-613
    CrossrefPubMedSearch in Google Scholar
  • 130 Pool ER, Porte M, Durham N, Urwin S, Laboi P, Martin F. Posterior reversible encephalopathy syndrome in HIV-positive patients: a case report and literature review. Int J STD AIDS 2018; 29 (09) 937-941
    CrossrefPubMedSearch in Google Scholar
  • 131 Hattori N, Yamamoto K, Kawaguchi Y. , et al. Early relapse of severe chronic active Epstein-Barr virus infection with posterior reversible encephalopathy syndrome after reduced intensity stem cell transplantation with umbilical cord blood. Leuk Lymphoma 2016; 57 (10) 2448-2451
    CrossrefPubMedSearch in Google Scholar
  • 132 Ito Y, Toyama K, Honda A, Nakazaki K, Arai S, Kurokawa M. Posterior reversible encephalopathy syndrome concurrent with human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation. J Infect Chemother 2019 Doi: 10.1016/j.jiac.2019.07.016
    Search in Google Scholar
  • 133 Kawamura Y, Ohashi M, Asahito H, Takahashi Y, Kojima S, Yoshikawa T. Posterior reversible encephalopathy syndrome in a child with post-transplant HHV-6B encephalitis. Bone Marrow Transplant 2012; 47 (10) 1381-1382
    CrossrefPubMedSearch in Google Scholar
  • 134 Kim SM, Choi H, Kim Y. , et al. Posterior reversible encephalopathy syndrome during recovery from acute kidney injury after hepatitis A infection. Case Rep Nephrol Urol 2012; 2 (01) 33-37
    CrossrefPubMedSearch in Google Scholar
  • 135 Sathyanarayanan V, Razak A, Narayan G. , et al. Posterior reversible encephalopathy syndrome in a patient with hepatitis B induced type 1 membranoproliferative glomerulonephritis. Clin Exp Nephrol 2010; 14 (06) 614-618
    CrossrefPubMedSearch in Google Scholar
  • 136 Fabrizi F, Paolucci A, Antonelli B. , et al. Hepatitis C virus-induced glomerular disease and posterior reversible encephalopathy syndrome after liver transplant: case report and literature review. Saudi J Kidney Dis Transpl 2019; 30 (01) 239-249
    CrossrefPubMedSearch in Google Scholar
  • 137 Bartynski WS, Upadhyaya AR, Boardman JF. Posterior reversible encephalopathy syndrome and cerebral vasculopathy associated with influenza A infection: report of a case and review of the literature. J Comput Assist Tomogr 2009; 33 (06) 917-922
    CrossrefPubMedSearch in Google Scholar
  • 138 Bartynski WS, Upadhyaya AR, Petropoulou KA, Boardman JF. Influenza A encephalopathy, cerebral vasculopathy, and posterior reversible encephalopathy syndrome: combined occurrence in a 3-year-old child. AJNR Am J Neuroradiol 2010; 31 (08) 1443-1446
    CrossrefPubMedSearch in Google Scholar
  • 139 Ogunneye O, Hernandez-Montfort JA, Ogunneye Y, Ogu I, Landry D. Parainfluenza virus infection associated with posterior reversible encephalopathy syndrome: a case report. J Med Case Reports 2012; 6: 89
    CrossrefPubMedSearch in Google Scholar
  • 140 Abraham A, Ziv S, Drory VE. Posterior reversible encephalopathy syndrome resulting from Guillain-Barré-like syndrome secondary to West Nile virus infection. J Clin Neuromuscul Dis 2011; 12 (03) 113-117
    CrossrefPubMedSearch in Google Scholar
  • 141 Kobatake M, Ishimaru N, Kanzawa Y, Seto H, Kinami S. Recurring posterior reversible encephalopathy syndrome in a patient with polymyositis/systemic sclerosis overlap syndrome triggered by scleroderma renal crisis. Eur J Rheumatol 2019; 6 (03) 158-160
    CrossrefPubMedSearch in Google Scholar
  • 142 Chen CY, Hung SY, Lee YJ, Lin YC, Pai CC. Delayed onset of posterior reversible encephalopathy syndrome in a case of scleroderma renal crisis with maintenance hemodialysis: case report and literature review. Medicine (Baltimore) 2016; 95 (52) e5725
    CrossrefPubMedSearch in Google Scholar
  • 143 Jeong HN, Suh BC, Kim YB, Chung PW, Moon HS, Yoon WT. Posterior reversible encephalopathy syndrome as an initial neurological manifestation of primary Sjögren's syndrome. Clin Auton Res 2015; 25 (04) 259-262
    CrossrefPubMedSearch in Google Scholar
  • 144 Rosa Júnior M, Borges ÉI, Fonseca APA, Fiorot JL, Balarini L, Valim V. Posterior reversible encephalopathy syndrome during treatment with tocilizumab in juvenile idiopathic arthritis. Arq Neuropsiquiatr 2018; 76 (10) 720-721
    CrossrefPubMedSearch in Google Scholar
  • 145 Kumar S, Rajam L. Posterior reversible encephalopathy syndrome (PRES/RPLS) during pulse steroid therapy in macrophage activation syndrome. Indian J Pediatr 2011; 78 (08) 1002-1004
    CrossrefPubMedSearch in Google Scholar
  • 146 Rahmanzadeh R, Rahmanzade R, Zabihiyeganeh M. Posterior reversible encephalopathy syndrome in a patient with mixed connective tissue disease: a case report. J Med Case Reports 2016; 10 (01) 145
    CrossrefPubMedSearch in Google Scholar
  • 147 Lee KW, Lee ST, Cho H. Posterior reversible encephalopathy syndrome caused by presumed Takayasu arteritis. Korean J Pediatr 2016; 59 (Suppl. 01) S145-S148
    CrossrefPubMedSearch in Google Scholar
  • 148 Alp A, Akdam H, Akar H. , et al. Polyarteritis nodosa complicated by posterior reversible encephalopathy syndrome: a case report. Nefrologia 2014; 34 (06) 789-796
    PubMedSearch in Google Scholar
  • 149 Lioger B, Diot E, Ebbo M. , et al; Société Nationale Française de Médecine Interne (SNFMI) and the CRI (Club Rhumatismes et Inflammation). Posterior reversible encephalopathy syndrome and systemic vasculitis: report of six cases. Clin Exp Rheumatol 2016; 34 (03) (Suppl. 97) S7-S11
    PubMedSearch in Google Scholar
  • 150 Dos Santos D, Langer FW, Dos Santos T, Rafael Tronco Alves G, Feiten M, Teixeira de Paula Neto W. Posterior reversible encephalopathy syndrome as a complication of Henoch-Schönlein purpura in a seven-year-old girl. Scott Med J 2017; 62 (01) 34-37
    CrossrefPubMedSearch in Google Scholar
  • 151 Marra A, Vargas M, Striano P, Del Guercio L, Buonanno P, Servillo G. Posterior reversible encephalopathy syndrome: the endothelial hypotheses. Med Hypotheses 2014; 82 (05) 619-622
    CrossrefPubMedSearch in Google Scholar
  • 152 Pruitt JH, Copeland III EM, Moldawer LL. Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock. Shock 1995; 3 (04) 235-251
    CrossrefPubMedSearch in Google Scholar
  • 153 Leopold JA. The endothelium. In: Creager M, Beckman JA, Loscalzo J. , eds. Vascular Medicine: A Companion to Braunwald's Heart Disease. 2nd ed. Philadelphia, PA: Elsevier Saunders; 2013: 17-31
    Search in Google Scholar
  • 154 Chae YK, Chiec L, Adney SK. , et al. Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review. Oncotarget 2018; 9 (46) 28281-28289
    CrossrefPubMedSearch in Google Scholar
  • 155 Agarwal A, Kapur G, Altinok D. Childhood posterior reversible encephalopathy syndrome: magnetic resonance imaging findings with emphasis on increased leptomeningeal FLAIR signal. Neuroradiol J 2015; 28 (06) 638-643
    CrossrefPubMedSearch in Google Scholar
  • 156 Kozak OS, Wijdicks EF, Manno EM, Miley JT, Rabinstein AA. Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 2007; 69 (09) 894-897
    CrossrefPubMedSearch in Google Scholar
  • 157 Panis B, Vlaar AM, van Well GT. , et al. Posterior reversible encephalopathy syndrome in paediatric leukaemia. Eur J Paediatr Neurol 2010; 14 (06) 539-545
    CrossrefPubMedSearch in Google Scholar
  • 158 Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol 2002; 249 (01) 9-17
    CrossrefPubMedSearch in Google Scholar
  • 159 Jeon JS, Park SP, Seo JG. Posterior reversible encephalopathy syndrome due to hyponatremia. J Epilepsy Res 2014; 4 (01) 31-33
    CrossrefPubMedSearch in Google Scholar
  • 160 Almoussa M, Goertzen A, Brauckmann S, Fauser B, Zimmermann CW. Posterior reversible encephalopathy syndrome due to hypomagnesemia: a case report and literature review. Case Rep Med 2018; 2018: 1980638
    CrossrefPubMedSearch in Google Scholar
  • 161 Chardain A, Mesnage V, Alamowitch S. , et al. Posterior reversible encephalopathy syndrome (PRES) and hypomagnesemia: a frequent association?. Rev Neurol (Paris) 2016; 172 (6–7): 384-388
    CrossrefPubMedSearch in Google Scholar
  • 162 Camara-Lemarroy CR, Gonzalez-Moreno EI, Ortiz-Corona JdeJ. , et al. Posterior reversible encephalopathy syndrome due to malignant hypercalcemia: physiopathological considerations. J Clin Endocrinol Metab 2014; 99 (04) 1112-1116
    CrossrefPubMedSearch in Google Scholar
  • 163 Dobrynina LA, Kalashnikova LA, Bakulin IS, Kremneva EI, Krotenkova MV, Shamtieva KV. Sindrom zadnei obratimoi entsefalopatii pri gipokal'tsiemii: opisanie nablyudeniya i analiz patogeneticheskoi znachimosti elektrolitnykh narushenii. Zh Nevrol Psikhiatr Im S S Korsakova 2016; 116 (07) 70-77
    PubMedSearch in Google Scholar
  • 164 Gera DN, Patil SB, Parikh M, Modi PR, Kute VB, Trivedi HL. Posterior reversible encephalopathy syndrome in setting of postobstructive diuresis and persistent hypocalcemia. Ren Fail 2012; 34 (09) 1166-1169
    CrossrefPubMedSearch in Google Scholar
  • 165 Sánchez-Carpintero R, Narbona J, López de Mesa R, Arbizu J, Sierrasesúmaga L. Transient posterior encephalopathy induced by chemotherapy in children. Pediatr Neurol 2001; 24 (02) 145-148
    CrossrefPubMedSearch in Google Scholar
  • 166 Alehan F, Erol I, Agildere AM. , et al. Posterior leukoencephalopathy syndrome in children and adolescents. J Child Neurol 2007; 22 (04) 406-413
    CrossrefPubMedSearch in Google Scholar
  • 167 Suminoe A, Matsuzaki A, Kira R. , et al. Reversible posterior leukoencephalopathy syndrome in children with cancers. J Pediatr Hematol Oncol 2003; 25 (03) 236-239
    CrossrefPubMedSearch in Google Scholar
  • 168 Kastrup O, Maschke M, Wanke I, Diener HC. Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol 2002; 249 (11) 1563-1566
    CrossrefPubMedSearch in Google Scholar
  • 169 Verhaegen J, Peeters F, Debois P, Jacquemyn Y. Posterior reversible encephalopathy syndrome as a complication of pre-eclampsia in the early postpartum period. BMJ Case Rep 2019; 12 (07) e228954
    CrossrefPubMedSearch in Google Scholar
  • 170 Sardesai S, Dabade R, Deshmukh S, Patil P, Pawar S, Patil A. Posterior reversible encephalopathy syndrome (PRES): evolving the mystery of eclampsia!. J Obstet Gynaecol India 2019; 69 (04) 334-338
    CrossrefPubMedSearch in Google Scholar
  • 171 Bosch BM, Bringard A, Ferretti G, Schwartz S, Iglói K. Effect of cerebral vasomotion during physical exercise on associative memory, a near-infrared spectroscopy study. Neurophotonics 2017; 4 (04) 041404
    CrossrefPubMedSearch in Google Scholar
  • 172 Charlot K, Antoine-Jonville S, Moeckesch B. , et al. Cerebral and muscle microvascular oxygenation in children with sickle cell disease: influence of hematology, hemorheology and vasomotion. Blood Cells Mol Dis 2017; 65: 23-28
    CrossrefPubMedSearch in Google Scholar
  • 173 Hoiland RL, Tymko MM, Bain AR, Wildfong KW, Monteleone B, Ainslie PN. Carbon dioxide-mediated vasomotion of extra-cranial cerebral arteries in humans: a role for prostaglandins?. J Physiol 2016; 594 (12) 3463-3481
    CrossrefPubMedSearch in Google Scholar
  • 174 Di Marco LY, Farkas E, Martin C, Venneri A, Frangi AF. Is vasomotion in cerebral arteries impaired in Alzheimer's disease?. J Alzheimers Dis 2015; 46 (01) 35-53
    CrossrefPubMedSearch in Google Scholar
  • 175 Thomsen AB, Kim S, Aalbaek F, Aalkjaer C, Boedtkjer E. Intracellular acidification alters myogenic responsiveness and vasomotion of mouse middle cerebral arteries. J Cereb Blood Flow Metab 2014; 34 (01) 161-168
    CrossrefPubMedSearch in Google Scholar
  • 176 Waltz X, Pichon A, Lemonne N. , et al. Normal muscle oxygen consumption and fatigability in sickle cell patients despite reduced microvascular oxygenation and hemorheological abnormalities. PLoS One 2012; 7 (12) e52471
    CrossrefPubMedSearch in Google Scholar
  • 177 Waltz X, Pichon A, Mougenel D. , et al. Hemorheological alterations, decreased cerebral microvascular oxygenation and cerebral vasomotion compensation in sickle cell patients. Am J Hematol 2012; 87 (12) 1070-1073
    CrossrefPubMedSearch in Google Scholar
  • 178 Horváth B, Lenzsér G, Benyó B. , et al. Hypersensitivity to thromboxane receptor mediated cerebral vasomotion and CBF oscillations during acute NO-deficiency in rats. PLoS One 2010; 5 (12) e14477
    CrossrefPubMedSearch in Google Scholar
  • 179 Lefer DJ, Lynch CD, Lapinski KC, Hutchins PM. Enhanced vasomotion of cerebral arterioles in spontaneously hypertensive rats. Microvasc Res 1990; 39 (02) 129-139
    CrossrefPubMedSearch in Google Scholar
  • 180 Osol G, Halpern W. Spontaneous vasomotion in pressurized cerebral arteries from genetically hypertensive rats. Am J Physiol 1988; 254 (1 Pt 2): H28-H33
    PubMedSearch in Google Scholar
  • 181 Kapor G. Posttraumatski poremećaj funkcije mozdanih vazomotora. Vojnosanit Pregl 1957; 14 (7–8): 415-419
    PubMedSearch in Google Scholar
  • 182 van Veluw SJ, Hou SS, Calvo-Rodriguez M. , et al. Vasomotion as a driving force for paravascular clearance in the awake mouse brain. Neuron 2019 Doi: 10.1016/j.neuron.2019.10.033
    Search in Google Scholar
  • 183 Iliff JJ, Wang M, Liao Y. , et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med 2012; 4 (147) 147ra111
    CrossrefPubMedSearch in Google Scholar
  • 184 Mestre H, Kostrikov S, Mehta RI, Nedergaard M. Perivascular spaces, glymphatic dysfunction, and small vessel disease. Clin Sci (Lond) 2017; 131 (17) 2257-2274
    CrossrefPubMedSearch in Google Scholar
  • 185 Nishi K, Tanegashima A, Yamamoto Y. , et al. Histochemical characteristic of perivascular space in the brain with an advanced edema. Leg Med (Tokyo) 2003; 5 (Suppl. 01) S280-S284
    CrossrefPubMedSearch in Google Scholar
  • 186 O'Hara McCoy H. Posterior reversible encephalopathy syndrome: an emerging clinical entity in adult, pediatric, and obstetric critical care. J Am Acad Nurse Pract 2008; 20 (02) 100-106
    CrossrefPubMedSearch in Google Scholar
  • 187 Dicuonzo F, Salvati A, Palma M. , et al. Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: conventional magnetic resonance and diffusion-weighted imaging findings. J Child Neurol 2009; 24 (08) 1013-1018
    CrossrefPubMedSearch in Google Scholar
  • 188 Umeda K, Yoshida M, Suzuki N. , et al. Complications in the central nervous system during chemotherapy for childhood acute lymphoblastic leukemia: JACLS ALL-02 study [article in Japanese]. Rinsho Ketsueki 2007; 48 (03) 204-211
    PubMedSearch in Google Scholar
  • 189 Appachu MS, Purohit S, Lakshmaiah KC, Kumari BS, Appaji L. Posterior reversible encephalopathy syndrome in pediatric acute leukemia: case series and literature review. Indian J Med Paediatr Oncol 2014; 35 (01) 79-82
    Thieme ConnectPubMedSearch in Google Scholar
  • 190 Arzanian MT, Shamsian BS, Karimzadeh P, Kajiyazdi M, Malek F, Hammoud M. Posterior reversible encephalopathy syndrome in pediatric hematologic-oncologic disease: literature review and case presentation. Iran J Child Neurol 2014; 8 (02) 1-10
    PubMedSearch in Google Scholar
  • 191 Araz C, Camkiran A, Zeyneloglu P. , et al. Early-onset posterior reversible encephalopathy syndrome after solid organ transplantation in pediatric patients: a report of 2 cases. Transplant Proc 2013; 45 (10) 3555-3557
    CrossrefPubMedSearch in Google Scholar
  • 192 Özçay F, Barış Z, Moray G, Haberal N, Torgay A, Haberal M. Report of 3 patients with urea cycle defects treated with related living-donor liver transplant. Exp Clin Transplant 2015; 13 (Suppl. 03) 126-130
    PubMedSearch in Google Scholar
  • 193 Sanchez-Montanez A, Morana G, Mancardi MM. , et al. Reversible cerebral vasoconstriction mimicking posterior reversible encephalopathy syndrome in an infant with end-stage renal disease. Cephalalgia 2015; 35 (11) 1031-1033
    CrossrefPubMedSearch in Google Scholar
  • 194 Loar RW, Patterson MC, O'Leary PW, Driscoll DJ, Johnson JN. Posterior reversible encephalopathy syndrome and hemorrhage associated with tacrolimus in a pediatric heart transplantation recipient. Pediatr Transplant 2013; 17 (02) E67-E70
    CrossrefPubMedSearch in Google Scholar
  • 195 Daniel NJ, Hernandez CL, Walker RA. Recurrent posterior reversible encephalopathy syndrome in a pediatric patient with end-stage renal disease. J Emerg Med 2014; 46 (02) e39-e42
    CrossrefPubMedSearch in Google Scholar
  • 196 Ergün T, Lakadamyali H, Yilmaz A. Recurrent posterior reversible encephalopathy syndrome in a hypertensive patient with end-stage renal disease. Diagn Interv Radiol 2008; 14 (04) 182-185
    PubMedSearch in Google Scholar
  • 197 Sato Y, Hirose M, Inoue Y. , et al. Reversible posterior leukoencephalopathy syndrome after blood transfusion in a patient with end-stage renal disease. Clin Exp Nephrol 2011; 15 (06) 942-947
    CrossrefPubMedSearch in Google Scholar
  • 198 Liman TG, Bohner G, Endres M, Siebert E. Discharge status and in-hospital mortality in posterior reversible encephalopathy syndrome. Acta Neurol Scand 2014; 130 (01) 34-39
    CrossrefPubMedSearch in Google Scholar
  • 199 Sharma A, Whitesell RT, Moran KJ. Imaging pattern of intracranial hemorrhage in the setting of posterior reversible encephalopathy syndrome. Neuroradiology 2010; 52 (10) 855-863
    CrossrefPubMedSearch in Google Scholar
  • 200 Gephart MG, Taft BP, Giese AK, Guzman R, Edwards MS. Perioperative posterior reversible encephalopathy syndrome in 2 pediatric neurosurgery patients with brainstem ependymoma. J Neurosurg Pediatr 2011; 7 (03) 235-237
    CrossrefPubMedSearch in Google Scholar
  • 201 Freedman D, Koram A, Gillson N, Aylward SC. Pediatric posterior reversible encephalopathy syndrome (PRES) with spinal cord involvement due to pheochromocytoma. Pediatr Neurol 2017; 77: 92-93
    CrossrefPubMedSearch in Google Scholar
  • 202 Lee G, Lee SE, Ryu KH, Yoo ES. Posterior reversible encephalopathy syndrome in pediatric patients undergoing treatment for hemophagocytic lymphohistiocytosis: clinical outcomes and putative risk factors. Blood Res 2013; 48 (04) 258-265
    CrossrefPubMedSearch in Google Scholar
  • 203 Kim DD, Budhram A, Haji FA, Leung A, Khaw A, Ramsay D. Leptomeningeal metastasis of classical Hodgkin lymphoma in a patient with malignant posterior reversible encephalopathy syndrome. Lancet Oncol 2019; 20 (07) e397
    CrossrefPubMedSearch in Google Scholar
  • 204 Sengupta S, Benkers T, Blitstein M, Palmer E, Plotkin SR, Abramson JS. Posterior reversible encephalopathy syndrome (PRES) complicating newly-diagnosed diffuse large B-cell lymphoma. Clin Lymphoma Myeloma Leuk 2014; 14 (04) e111-e113
    CrossrefPubMedSearch in Google Scholar
  • 205 Roy S, Gandhi AK, Jana M, Julka PK. Recurrent posterior reversible encephalopathy syndrome after chemotherapy in hematologic malignancy-posterior reversible encephalopathy syndrome can strike twice!!!. J Cancer Res Ther 2014; 10 (02) 393-396
    CrossrefPubMedSearch in Google Scholar
  • 206 Papayannidis C, Volpato F, Iacobucci I, Abbenante MC, Sartor C, Martinelli G. Posterior reversible encephalopathy syndrome in a B-cell acute lymphoblastic leukemia young adult patient treated with a pediatric-like chemotherapeutic schedule. Hematol Rep 2014; 6 (03) 5565
    CrossrefPubMedSearch in Google Scholar
  • 207 Patejdl R, Borchert K, Pagumbke H, Benecke R, Grossmann A, Prall F, Kahl C, Freund M, Schmitt M, Walter U. Posterior reversible encephalopathy syndrome (PRES): an unusual primary manifestation of a diffuse large B-cell lymphoma. Clin Neurol Neurosurg 2011; 113 (09) 819-821
    CrossrefPubMedSearch in Google Scholar
  • 208 Guvenc B, Canataroglu A, Unsal C. , et al. β-Globin chain abnormalities with coexisting α-thalassemia mutations. Arch Med Sci 2012; 8 (04) 644-649
    CrossrefPubMedSearch in Google Scholar
  • 209 Erer B, Polchi P, Lucarelli G. , et al. CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors. Bone Marrow Transplant 1996; 18 (01) 157-162
    PubMedSearch in Google Scholar
  • 210 Zhang Y, Lu Z, Li Y. , et al. Posterior reversible encephalopathy syndrome with essential thrombocythemia: a case report. Medicine (Baltimore) 2019; 98 (34) e16759
    CrossrefPubMedSearch in Google Scholar
  • 211 Fidan K, Kandur Y, Ucar M, Gucuyener K, Soylemezoglu O. Posterior reversible encephalopathy syndrome in Henoch-Schonlein purpura and hemolytic uremic syndrome. J Clin Med Res 2016; 8 (07) 544-547
    CrossrefPubMedSearch in Google Scholar
  • 212 Hage P, Kseib C, Hmaimess G, Jaoude PA, Noun P. Recurrent posterior reversible encephalopathy syndrome with cerebellar involvement leading to acute hydrocephalus. Clin Neurol Neurosurg 2018; 172: 120-123
    CrossrefPubMedSearch in Google Scholar
  • 213 Sigurtà A, Terzi V, Regna-Gladin C, Fumagalli R. Posterior reversible encephalopathy syndrome complicating traumatic pancreatitis: a pediatric case report. Medicine (Baltimore) 2016; 95 (22) e3758
    CrossrefPubMedSearch in Google Scholar
  • 214 Tassinari D, Bergamaschi R, Corsini I. , et al. Posterior reversible encephalopathy syndrome associated with licorice consumption: a case report in a 10-year-old boy. Pediatr Neurol 2015; 52 (04) 457-459
    CrossrefPubMedSearch in Google Scholar
  • 215 Yoon JE, Lee CY, Kim HW. Posterior reversible encephalopathy syndrome after head trauma surgery in pediatric patient without any underlying disease. Korean J Neurotrauma 2017; 13 (02) 167-170
    CrossrefPubMedSearch in Google Scholar
  • 216 San Martín García I, Urabayen Alberdi R, Díez Bayona V. , et al. Síndrome de encefalopatía posterior reversible: 5 casos relacionados con quimioterapia. An Pediatr (Barc) 2014; 80 (02) 117-121
    CrossrefPubMedSearch in Google Scholar
  • 217 Lewis MB. Cyclosporin neurotoxicity after chemotherapy. Cyclosporin causes reversible posterior leukoencephalopathy syndrome. BMJ 1999; 319 (7201): 54-55
    CrossrefPubMedSearch in Google Scholar
  • 218 Kur JK, Esdaile JM. Posterior reversible encephalopathy syndrome--an underrecognized manifestation of systemic lupus erythematosus. J Rheumatol 2006; 33 (11) 2178-2183
    PubMedSearch in Google Scholar
  • 219 Koch S, Rabinstein A, Falcone S, Forteza A. Diffusion-weighted imaging shows cytotoxic and vasogenic edema in eclampsia. Am J Neuroradiol 2001; 22 (06) 1068-1070
    PubMedSearch in Google Scholar
  • 220 Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. Am J Neuroradiol 2006; 27 (10) 2179-2190
    PubMedSearch in Google Scholar
  • 221 Ocaña Rico M, Javier Manchón G, Coroleu Lletget W, Capellades Font J. Encefalopatía posterior reversible durante el tratamiento de inducción de la leucemia linfoblástica aguda. Med Clin (Barc) 2002; 119 (20) 795-796
    CrossrefPubMedSearch in Google Scholar
  • 222 Wong R, Beguelin GZ, de Lima M. , et al. Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2003; 122 (01) 128-134
    CrossrefPubMedSearch in Google Scholar
  • 223 Ito Y, Arahata Y, Goto Y. , et al. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. Am J Neuroradiol 1998; 19 (03) 415-417
    PubMedSearch in Google Scholar
  • 224 Hamid M, Ghani A, Micaily I, Sarwar U, Lashari B, Malik F. Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer. J Community Hosp Intern Med Perspect 2018; 8 (03) 130-133
    CrossrefPubMedSearch in Google Scholar
  • 225 Hualde Olascoaga J, Molins Castiella T, Souto Hernández S. , et al. Leucoencefalopatía posterior reversible: descripción de dos casos asociados a vincristina. An Pediatr (Barc) 2008; 68 (03) 282-285
    CrossrefPubMedSearch in Google Scholar
  • 226 Abbas O, Shamseddin A, Temraz S, Haydar A. Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patient. BMJ Case Rep 2013 2013. . pii: bcr2012007995. Doi: 10.1136/bcr-2012-007995
    Search in Google Scholar
  • 227 Sengupta P, Biswas S. Dialysis disequilibrium leading to posterior reversible encephalopathy syndrome in chronic renal failure. CEN Case Rep 2016; 5 (02) 154-157
    CrossrefPubMedSearch in Google Scholar
  • 228 McDermott M, Miller EC, Rundek T, Hurn PD, Bushnell CD. Preeclampsia: association with posterior reversible encephalopathy syndrome and stroke. Stroke 2018; 49 (03) 524-530
    CrossrefPubMedSearch in Google Scholar
  • 229 Burrus TM, Wijdicks EF, Rabinstein AA. Brain lesions are most often reversible in acute thrombotic thrombocytopenic purpura. Neurology 2009; 73 (01) 66-70
    CrossrefPubMedSearch in Google Scholar
  • 230 Fukami T, Asakura H, Takeshita T. Reversible posterior leukoencephalopathy syndrome due to eclampsia in a woman with a twin pregnancy produced with donated oocytes. J Nippon Med Sch 2013; 80 (03) 230-233
    CrossrefPubMedSearch in Google Scholar
  • 231 Ishikura K, Hamasaki Y, Sakai T, Hataya H, Mak RH, Honda M. Posterior reversible encephalopathy syndrome in children with kidney diseases. Pediatr Nephrol 2012; 27 (03) 375-384
    CrossrefPubMedSearch in Google Scholar
  • 232 Gaziev J, Marziali S, Paciaroni K. , et al. Posterior reversible encephalopathy syndrome after hematopoietic cell transplantation in children with hemoglobinopathies. Biol Blood Marrow Transplant 2017; 23 (09) 1531-1540
    CrossrefPubMedSearch in Google Scholar
  • 233 Schmidt V, Prell T, Treschl A, Klink A, Hochhaus A, Sayer HG. Clinical management of posterior reversible encephalopathy syndrome after allogeneic hematopoietic stem cell transplantation: a case series and review of the literature. Acta Haematol 2016; 135 (01) 1-10
    CrossrefPubMedSearch in Google Scholar
  • 234 Cordelli DM, Masetti R, Bernardi B. , et al. Status epilepticus as a main manifestation of posterior reversible encephalopathy syndrome after pediatric hematopoietic stem cell transplantation. Pediatr Blood Cancer 2012; 58 (05) 785-790
    CrossrefPubMedSearch in Google Scholar
  • 235 Bartynski WS, Zeigler Z, Spearman MP, Lin L, Shadduck RK, Lister J. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR Am J Neuroradiol 2001; 22 (10) 1901-1914
    PubMedSearch in Google Scholar
  • 236 Jarosz JM, Howlett DC, Cox TC, Bingham JB. Cyclosporine-related reversible posterior leukoencephalopathy: MRI. Neuroradiology 1997; 39 (10) 711-715
    CrossrefPubMedSearch in Google Scholar
  • 237 Reinohs M, Straube T, Baum P, Berrouschot J, Wagner A. Recurrent reversible cerebral edema after long term immunosuppression with tacrolimus. J Neurol 2002; 249 (06) 780-781
    CrossrefPubMedSearch in Google Scholar
  • 238 Vaughn DJ, Jarvik JG, Hackney D, Peters S, Stadtmauer EA. High-dose cytarabine neurotoxicity: MR findings during the acute phase. AJNR Am J Neuroradiol 1993; 14 (04) 1014-1016
    Search in Google Scholar
  • 239 Feinberg WM, Swenson MR. Cerebrovascular complications of L-asparaginase therapy. Neurology 1988; 38 (01) 127-133
    CrossrefPubMedSearch in Google Scholar
  • 240 Inaba H, Khan RB, Laningham FH, Crews KR, Pui CH, Daw NC. Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol 2008; 19 (01) 178-184
    CrossrefPubMedSearch in Google Scholar
  • 241 Miese FR, Schuster FR, Pierstorff K. , et al. Magnetization transfer imaging provides no evidence of demyelination in methotrexate-induced encephalopathy. AJNR Am J Neuroradiol 2011; 32 (06) E110-E112
    CrossrefPubMedSearch in Google Scholar
  • 242 Rota E, Vallisa D, Morelli N, Scagnelli P. Iatrogenic coagulopathy and the development of posterior reversible encephalopathy syndrome after L-asparaginase chemotherapy. J Clin Imaging Sci 2016; 6: 7
    CrossrefPubMedSearch in Google Scholar
  • 243 Titos-Arcos JC, León-Villar J, Amigo-Lozano ML, Muiña-Juárez B. Síndrome de leucoencefalopatía posterior reversible inducida por L-asparaginasa en una adolescente diagnosticada de leucemia linfoblástica aguda. Rev Neurol 2011; 52 (01) 58-60
    PubMedSearch in Google Scholar
  • 244 Kieslich M, Porto L, Lanfermann H, Jacobi G, Schwabe D, Böhles H. Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2003; 25 (06) 484-487
    CrossrefPubMedSearch in Google Scholar
  • 245 Pound CM, Keene DL, Udjus K, Humphreys P, Johnston DL. Acute encephalopathy and cerebral vasospasm after multiagent chemotherapy including PEG-asparaginase and intrathecal cytarabine for the treatment of acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2007; 29 (03) 183-186
    CrossrefPubMedSearch in Google Scholar
  • 246 Nomme J, Su Y, Konrad M, Lavie A. Structures of apo and product-bound human L-asparaginase: insights into the mechanism of autoproteolysis and substrate hydrolysis. Biochemistry 2012; 51 (34) 6816-6826
    CrossrefPubMedSearch in Google Scholar
  • 247 Minn AY, Fisher PG, Barnes PD, Dahl GV. A syndrome of irreversible leukoencephalopathy following pediatric allogeneic bone marrow transplantation. Pediatr Blood Cancer 2007; 48 (02) 213-217
    CrossrefPubMedSearch in Google Scholar
  • 248 Siegal D, Keller A, Xu W. , et al. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. Biol Blood Marrow Transplant 2007; 13 (11) 1369-1379
    CrossrefPubMedSearch in Google Scholar
  • 249 Kanekiyo T, Hara J, Matsuda-Hashii Y. , et al. Tacrolimus-related encephalopathy following allogeneic stem cell transplantation in children. Int J Hematol 2005; 81 (03) 264-268
    CrossrefPubMedSearch in Google Scholar
  • 250 Bartynski WS, Zeigler ZR, Shadduck RK, Lister J. Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation. Am J Neuroradiol 2004; 25 (02) 261-269
    PubMedSearch in Google Scholar
  • 251 Stott VL, Hurrell MA, Anderson TJ. Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J 2005; 35 (02) 83-90
    CrossrefPubMedSearch in Google Scholar
  • 252 Wittgrove C, Kaur H, Siddiqui JH. Atypical variant of posterior reversible encephalopathy syndrome in the setting of renovascular hypertension: case report and review of literature. Cureus 2018; 10 (11) e3573
    PubMedSearch in Google Scholar
  • 253 Gowan JM, Liu A. Isolated pan-pontine posterior reversible encephalopathy syndrome in a patient with uncontrolled hypertension. Clin Case Rep 2018; 7 (01) 32-36
    CrossrefPubMedSearch in Google Scholar
  • 254 Lee MK, Cho YJ, Lee SK, Jung SK, Heo K. The effect of presymptomatic hypertension in posterior reversible encephalopathy syndrome. Brain Behav 2018; 8 (12) e01190
    CrossrefPubMedSearch in Google Scholar
  • 255 Tam CS, Galanos J, Seymour JF, Pitman AG, Stark RJ, Prince HM. Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies. Am J Hematol 2004; 77 (01) 72-76
    CrossrefPubMedSearch in Google Scholar
  • 256 Straathof K, Anoop P, Allwood Z. , et al. Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2017; 52 (01) 159-162
    CrossrefPubMedSearch in Google Scholar
  • 257 Thompson D, Harrington Y, de la Fuente J. The incidence of posterior reversible encephalopathy syndrome is increased in BMT for haemoglobinopathies. Blood 2013; 122 (21) 4579
    CrossrefPubMedSearch in Google Scholar
  • 258 Shenoy S, Eapen M, Panepinto JA. , et al. A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. Blood 2016; 128 (21) 2561-2567
    CrossrefPubMedSearch in Google Scholar
  • 259 Noè A, Cappelli B, Biffi A. , et al. High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome. Ital J Pediatr 2010; 36: 14
    CrossrefPubMedSearch in Google Scholar
  • 260 Vargas A, Testai FD. Posterior reversible encephalopathy syndrome in adult sickle-cell patients: case series and literature review. J Clin Neurosci 2019; 70: 249-250
    CrossrefPubMedSearch in Google Scholar
  • 261 Bhunia N, Abu-Arja R, Bajwa RPS, Auletta JJ, Rangarajan HG. Successful treatment with eculizumab for posterior reversible encephalopathy syndrome due to underlying transplant-associated thrombotic microangiopathy in patients transplanted for sickle cell disease. Pediatr Blood Cancer 2019; 66 (10) e27912
    CrossrefPubMedSearch in Google Scholar
  • 262 Hanafy E, Alshareef D, Osman S, Al Jabri A, Nazim F, Mahmoud G. Posterior reversible encephalopathy syndrome secondary to asymptomatic poststreptococcal glomerulonephritis in a child with sickle cell anemia: a case report. J Med Case Reports 2018; 12 (01) 24
    CrossrefPubMedSearch in Google Scholar
  • 263 Solh Z, Taccone MS, Marin S, Athale U, Breakey VR. Neurological PRESentations in sickle cell patients are not always stroke: a review of posterior reversible encephalopathy syndrome in sickle cell disease. Pediatr Blood Cancer 2016; 63 (06) 983-989
    CrossrefPubMedSearch in Google Scholar
  • 264 Landais A, Lemonne N, Etienne-Julan M. Uncommon posterior reversible encephalopathy syndrome in a sickle-cell patient. J Clin Neurol 2015; 11 (03) 287-288
    CrossrefPubMedSearch in Google Scholar
  • 265 Regling K, Pomerantz D, Narayanan S, Altinok D, Sivaswamy L, Marupudi NI, Callaghan MU, Martin A. Reversible cerebral vasoconstriction syndrome and sickle cell disease: a case report. J Pediatr Hematol Oncol 2019 . Doi: 10.1097/MPH.0000000000001683
    Search in Google Scholar
  • 266 Bachmeyer C, Favrole P, Marro B, Stankovic Stojanovic K, Lionnet F. Syndrome d'encéphalopathie postérieure réversible chez une adulte drépanocytaire homozygote. Presse Med 2013; 42 (03) 373-374
    CrossrefPubMedSearch in Google Scholar
  • 267 Nair A, Testai FD. Recurrent posterior reversible encephalopathy syndrome in a sickle cell patient. J Natl Med Assoc 2011; 103 (02) 170-172
    CrossrefPubMedSearch in Google Scholar
  • 268 Farooq S, Testai FD. Neurologic complications of sickle cell disease. Curr Neurol Neurosci Rep 2019; 19 (04) 17
    CrossrefPubMedSearch in Google Scholar
  • 269 Matsui A, Ikeuchi H, Shimizu A, Takahashi S, Mishima K, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Hiromura K, Nojima Y. Case report: posterior reversible encephalopathy syndrome and scleroderma renal crisis developed in a patient with overlap syndrome after treatment with high-dose steroids and tacrolimus [in Japanese]. Nihon Naika Gakkai Zasshi 2012; 101 (07) 2051-2054
    CrossrefPubMedSearch in Google Scholar
  • 270 Pedraza MI, Barbado J, Ruiz M, Guerrero ÁL. Posterior reversible encephalopathy syndrome as presenting form of very early systemic sclerosis. Case Rep Neurol Med 2015; 2015: 290378
    PubMedSearch in Google Scholar
  • 271 Lai CC, Chen WS, Chang YS. , et al. Clinical features and outcomes of posterior reversible encephalopathy syndrome in patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2013; 65 (11) 1766-1774
    CrossrefPubMedSearch in Google Scholar
  • 272 Shaharir SS, Remli R, Marwan AA, Said MS, Kong NC. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus: pooled analysis of the literature reviews and report of six new cases. Lupus 2013; 22 (05) 492-496
    CrossrefPubMedSearch in Google Scholar
  • 273 Jung SM, Moon SJ, Kwok SK. , et al. Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome. Lupus 2013; 22 (09) 885-891
    CrossrefPubMedSearch in Google Scholar
  • 274 Fujieda Y, Kataoka H, Odani T. , et al. Clinical features of reversible posterior leukoencephalopathy syndrome in patients with systemic lupus erythematosus. Mod Rheumatol 2011; 21 (03) 276-281
    CrossrefPubMedSearch in Google Scholar
  • 275 Magaña SM, Matiello M, Pittock SJ. , et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 2009; 72 (08) 712-717
    CrossrefPubMedSearch in Google Scholar
  • 276 Boehm C, Kazazian Jr HH. Prenatal diagnosis of hemoglobinopathies by DNA analysis. Crit Rev Oncol Hematol 1985; 4 (02) 155-167
    CrossrefPubMedSearch in Google Scholar
  • 277 Weatherall DJ, Wood WG, Jones RW, Clegg JB. The developmental genetics of human hemoglobin. Prog Clin Biol Res 1985; 191: 3-25
    PubMedSearch in Google Scholar
  • 278 Steinberg MH. Pathophysiology of sickle cell disease. Baillieres Clin Haematol 1998; 11 (01) 163-184
    CrossrefPubMedSearch in Google Scholar
  • 279 Elion J, Laurance S, Lapouméroulie C. Pathophysiology of sickle cell disease [in French]. Med Trop (Mars) 2010; 70 (5–6): 454-458
    PubMedSearch in Google Scholar
  • 280 Conran N, Franco-Penteado CF, Costa FF. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion. Hemoglobin 2009; 33 (01) 1-16
    CrossrefPubMedSearch in Google Scholar
  • 281 Brugnara C. Sickle cell disease: from membrane pathophysiology to novel therapies for prevention of erythrocyte dehydration. J Pediatr Hematol Oncol 2003; 25 (12) 927-933
    CrossrefPubMedSearch in Google Scholar
  • 282 Brugnara C. Erythrocyte dehydration in pathophysiology and treatment of sickle cell disease. Curr Opin Hematol 1995; 2 (02) 132-138
    CrossrefPubMedSearch in Google Scholar
  • 283 Noguchi CT, Schechter AN, Rodgers GP. Sickle cell disease pathophysiology. Baillieres Clin Haematol 1993; 6 (01) 57-91
    CrossrefPubMedSearch in Google Scholar
  • 284 Quimby KR, Hambleton IR, Landis RC. Intravenous infusion of haptoglobin for the prevention of adverse clinical outcome in sickle cell disease. Med Hypotheses 2015; 85 (04) 424-432
    CrossrefPubMedSearch in Google Scholar
  • 285 Potoka KP, Gladwin MT. Vasculopathy and pulmonary hypertension in sickle cell disease. Am J Physiol Lung Cell Mol Physiol 2015; 308 (04) L314-L324
    CrossrefPubMedSearch in Google Scholar
  • 286 Abboud MR, Musallam KM. Sickle cell disease at the dawn of the molecular era. Hemoglobin 2009; 33 (Suppl. 01) S93-S106
    CrossrefPubMedSearch in Google Scholar
  • 287 Corvest V, Blais S, Dahmani B. , et al. Vasculopathie cérébrale de l'enfant drépanocytaire : points clés et nouveautés. Arch Pediatr 2018; 25 (01) 63-71
    CrossrefPubMedSearch in Google Scholar
  • 288 Raj AB, O'brien LM, Bertolone SJ, Gozal D, Edmonds Jr HL. Cerebral oximetry improves detection of sickle cell patients at risk for nocturnal cerebral hypoxia. Pediatr Pulmonol 2006; 41 (11) 1088-1094
    CrossrefPubMedSearch in Google Scholar
  • 289 Arnow PM, Panwalker A, Garvin JS, Rodriguez-Erdmann F. Aspirin, hyperventilation, and cerebellar infarction in sickle cell disease. Arch Intern Med 1978; 138 (01) 148-149
    CrossrefPubMedSearch in Google Scholar
  • 290 Vetri F, Menicucci D, Lapi D, Gemignani A, Colantuoni A. Pial arteriolar vasomotion changes during cortical activation in rats. Neuroimage 2007; 38 (01) 25-33
    CrossrefPubMedSearch in Google Scholar
  • 291 Bertuglia S, Colantuoni A, Coppini G, Intaglietta M. Hypoxia- or hyperoxia-induced changes in arteriolar vasomotion in skeletal muscle microcirculation. Am J Physiol 1991; 260 (2 Pt 2): H362-H372
    PubMedSearch in Google Scholar
  • 292 Kaul DK, Fabry ME. In vivo studies of sickle red blood cells. Microcirculation 2004; 11 (02) 153-165
    PubMedSearch in Google Scholar
  • 293 Rodgers GP, Schechter AN, Noguchi CT, Klein HG, Nienhuis AW, Bonner RF. Periodic microcirculatory flow in patients with sickle-cell disease. N Engl J Med 1984; 311 (24) 1534-1538
    CrossrefPubMedSearch in Google Scholar
  • 294 Lipowsky HH, Sheikh NU, Katz DM. Intravital microscopy of capillary hemodynamics in sickle cell disease. J Clin Invest 1987; 80 (01) 117-127
    CrossrefPubMedSearch in Google Scholar
  • 295 Fukuyama T, Tanaka M, Nakazawa Y. , et al. Prophylactic treatment for hypertension and seizure in a case of allogeneic hematopoietic stem cell transplantation after posterior reversible encephalopathy syndrome. Pediatr Transplant 2011; 15 (08) E169-E173
    CrossrefPubMedSearch in Google Scholar
  • 296 Nasri A, Bedoui I, Mrissa R. , et al. Recurrent status epilepticus in posterior reversible encephalopathy syndrome as initial feature of pediatric lupus: a newly diagnosed case and literature review. Brain Dev 2016; 38 (09) 835-841
    CrossrefPubMedSearch in Google Scholar
  • 297 Datar S, Singh T, Rabinstein AA, Fugate JE, Hocker S. Long-term risk of seizures and epilepsy in patients with posterior reversible encephalopathy syndrome. Epilepsia 2015; 56 (04) 564-568
    CrossrefPubMedSearch in Google Scholar
  • 298 Li R, Mitchell P, Dowling R, Yan B. Is hypertension predictive of clinical recurrence in posterior reversible encephalopathy syndrome?. J Clin Neurosci 2013; 20 (02) 248-252
    CrossrefPubMedSearch in Google Scholar
  • 299 Ghali MGZ, Davanzo J, Leo M, Rizk E. Posterior reversible encephalopathy syndrome in pediatric patients: pathophysiology, diagnosis, and management. Leuk Lymphoma 2019; 60: 2365-2372
    CrossrefPubMedSearch in Google Scholar
  • 300 Gümüş H, Per H, Kumandaş S, Yikilmaz A. Reversible posterior leukoencephalopathy syndrome in childhood: report of nine cases and review of the literature. Neurol Sci 2010; 31 (02) 125-131
    CrossrefPubMedSearch in Google Scholar
  • 301 de Laat P, Te Winkel ML, Devos AS, Catsman-Berrevoets CE, Pieters R, van den Heuvel-Eibrink MM. Posterior reversible encephalopathy syndrome in childhood cancer. Ann Oncol 2011; 22 (02) 472-478
    CrossrefPubMedSearch in Google Scholar
  • 302 McKinney AM, Sarikaya B, Gustafson C, Truwit CL. Detection of microhemorrhage in posterior reversible encephalopathy syndrome using susceptibility-weighted imaging. AJNR Am J Neuroradiol 2012; 33 (05) 896-903
    CrossrefPubMedSearch in Google Scholar
  • 303 Liang H, Xu Z, Zheng Z, Lou H, Yue W. Reversible cerebral vasoconstriction syndrome following red blood cells transfusion: a case series of 7 patients. Orphanet J Rare Dis 2015; 10: 47
    CrossrefPubMedSearch in Google Scholar
  • 304 Kamide T, Tsutsui T, Misaki K. , et al. A pediatric case of reversible cerebral vasoconstriction syndrome with similar radiographic findings to posterior reversible encephalopathy syndrome. Pediatr Neurol 2017; 71: 73-76
    CrossrefPubMedSearch in Google Scholar
  • 305 Liu L, Dai D, Cao F, Zhang L, Wang X. Posterior reversible encephalopathy syndrome with spinal cord involvement but without hemisphere lesions: a case report. Medicine (Baltimore) 2019; 98: e13649
    CrossrefPubMedSearch in Google Scholar
  • 306 Baytan B, Evim MS, Güler S, Güneş AM, Okan M. Acute central nervous system complications in pediatric acute lymphoblastic leukemia. Pediatr Neurol 2015; 53 (04) 312-318
    CrossrefPubMedSearch in Google Scholar
  • 307 Gupta V, Bhatia V, Khandelwal N, Singh P, Singhi P. Imaging findings in pediatric posterior reversible encephalopathy syndrome (PRES): 5 years of experience from a tertiary care center in India. J Child Neurol 2016; 31 (09) 1166-1173
    CrossrefPubMedSearch in Google Scholar
  • 308 Kastrup O, Schlamann M, Moenninghoff C, Forsting M, Goericke S. Posterior reversible encephalopathy syndrome: the spectrum of MR imaging patterns. Clin Neuroradiol 2015; 25 (02) 161-171
    CrossrefPubMedSearch in Google Scholar
  • 309 Ettinger N, Pearson M, Lamb FS, Wellons III JC. Pediatric posterior reversible encephalopathy syndrome presenting with isolated cerebellar edema and obstructive hydrocephalus. J Neurosurg Pediatr 2014; 14 (04) 344-347
    CrossrefPubMedSearch in Google Scholar
  • 310 Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. Am J Neuroradiol 2007; 28 (07) 1320-1327
    CrossrefPubMedSearch in Google Scholar
  • 311 Ni J, Zhou LX, Hao HL. , et al. The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: a retrospective series of 24 patients. J Neuroimaging 2011; 21 (03) 219-224
    CrossrefPubMedSearch in Google Scholar
  • 312 Siebert E, Spors B, Bohner G, Endres M, Liman TG. Posterior reversible encephalopathy syndrome in children: radiological and clinical findings - a retrospective analysis of a German tertiary care center. Eur J Paediatr Neurol 2013; 17 (02) 169-175
    CrossrefPubMedSearch in Google Scholar
  • 313 Gao B, Liu FL, Zhao B. Association of degree and type of edema in posterior reversible encephalopathy syndrome with serum lactate dehydrogenase level: initial experience. Eur J Radiol 2012; 81 (10) 2844-2847
    CrossrefPubMedSearch in Google Scholar
  • 314 Vargas M, Servillo G, Striano P. Serum lactate dehydrogenase as early marker of posterior reversible encephalopathy syndrome: keep your eyes open. Anaesth Intensive Care 2012; 40 (03) 570-571
    PubMedSearch in Google Scholar
  • 315 Yamagishi H, Chen-Yoshikawa TF, Date H. Basiliximab for posterior reversible encephalopathy syndrome after lung transplantation. Eur J Cardiothorac Surg 2017; 52 (04) 823-824
    CrossrefPubMedSearch in Google Scholar
  • 316 Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 2000; 13 (05) 313-326
    CrossrefPubMedSearch in Google Scholar
  • 317 Antunes NL, Small TN, George D, Boulad F, Lis E. Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol 1999; 20 (03) 241-243
    CrossrefPubMedSearch in Google Scholar
  • 318 Dawson DG, Trobe JD. Blindness after liver transplant. Surv Ophthalmol 2002; 47 (04) 387-391
    CrossrefPubMedSearch in Google Scholar
  • 319 Tallaksen CM, Kerty E, Bakke S. Visual hallucinations in a case of reversible hypertension-induced brain oedema. Eur J Neurol 1998; 5 (06) 615-618
    CrossrefPubMedSearch in Google Scholar
  • 320 Sweany JM, Bartynski WS, Boardman JF. “Recurrent” posterior reversible encephalopathy syndrome: report of 3 cases--PRES can strike twice!. J Comput Assist Tomogr 2007; 31 (01) 148-156
    CrossrefPubMedSearch in Google Scholar
  • 321 Woodard P, Helton K, McDaniel H. , et al. Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis. Bone Marrow Transplant 2004; 33 (11) 1151-1157
    CrossrefPubMedSearch in Google Scholar
  • 322 Thaipisuttikul I, Phanthumchinda K. Recurrent reversible posterior leukoencephalopathy in a patient with systemic lupus erythematosus. J Neurol 2005; 252 (02) 230-231
    CrossrefPubMedSearch in Google Scholar
  • 323 Finsterer J, Stöllberger C, Ostermann E, Zuntner G, Huber J, Tscherney R. Recurrent posterior reversible encephalopathy syndrome in mitochondrial disorder. Blood Press 2009; 18 (03) 126-129
    CrossrefPubMedSearch in Google Scholar
  • 324 Grossbach AJ, Abel TJ, Hodis B, Wassef SN, Greenlee JD. Hypertensive posterior reversible encephalopathy syndrome causing posterior fossa edema and hydrocephalus. J Clin Neurosci 2014; 21 (02) 207-211
    CrossrefPubMedSearch in Google Scholar
  • 325 Lee SY, Dinesh SK, Thomas J. Hypertension-induced reversible posterior leukoencephalopathy syndrome causing obstructive hydrocephalus. J Clin Neurosci 2008; 15 (04) 457-459
    CrossrefPubMedSearch in Google Scholar
  • 326 Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008; 65 (02) 205-210
    PubMedSearch in Google Scholar
  • 327 Arslan H, Yavuz A, Arslan A, Aycan A. Posterior reversible encephalopathy syndrome in IgA vasculitis: neuroimaging of a 14-year-old child. Neurol Neurochir Pol 2018; 52 (01) 107-111
    CrossrefPubMedSearch in Google Scholar
  • 328 Camara-Lemarroy CR, Cruz-Moreno MA, Gamboa-Sarquis RN, Gonzalez-Padilla KA, Tamez-Perez HE, Galarza-Delgado DA. Goodpasture syndrome and posterior reversible encephalopathy syndrome. J Neurol Sci 2015; 354 (1–2): 135-137
    CrossrefPubMedSearch in Google Scholar
  • 329 Swarnalatha G, Ram R, Pai BH, Dakshinamurty KV. Posterior reversible encephalopathy syndrome in minimal change disease. Indian J Nephrol 2012; 22 (02) 153-154
    CrossrefPubMedSearch in Google Scholar
  • 330 Stârcea M, Gavrilovici C, Munteanu M, Miron I. Focal segmental glomerulosclerosis in children complicated by posterior reversible encephalopathy syndrome. J Int Med Res 2018; 46 (03) 1172-1177
    CrossrefPubMedSearch in Google Scholar
  • 331 Cha B, Kim DY, Jang H, Hwang SD, Choi HJ, Kim MJ. Unusual case of posterior reversible encephalopathy syndrome in a patient with anti-glomerular basement membrane antibody glomerulonephritis: a case report and review of the literature. Electrolyte Blood Press 2017; 15 (01) 12-16
    CrossrefPubMedSearch in Google Scholar
  • 332 Yadla M, Sailaja S, Bottu M, Uppin M. An unusual case of idiopathic crescentic membranoproliferative glomerulonephritis with posterior reversible encephalopathy syndrome. Saudi J Kidney Dis Transpl 2016; 27 (04) 825-827
    CrossrefPubMedSearch in Google Scholar